Omega Fund Management, LLC

CIK 0001637359 · BOSTON, MA · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Omega Fund Management, LLC reported 10 positions worth $185.7M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: BCAX (29.1%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$185.7M
2026 Q2
Positions
10
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
2026 Q2
10 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1BCAXBicara Therapeutics Inc.SH$54.1M29.14%1,822,150
2NUVBNuvation Bio Inc.SH$45.9M24.72%8,081,089
3KMTSKestra Med Technologies LtdSH$26.0M14.00%1,022,149
4BBOTBridgeBio Oncology Therapeutics Inc.SH$25.1M13.50%3,289,661
5BBNXBeta Bionics Inc.SH$20.6M11.11%1,316,183
6ALMSAlumis Inc.SH$6.8M3.66%241,255
7SANASana Biotechnology, Inc.SH$2.9M1.59%843,750
8IMAImageneBio, Inc.SH$2.7M1.45%455,361
929286M105enGene Holdings Inc.SH$1.5M0.82%876,357
10ODTXOdyssey Therapeutics Inc.SH$54.1K0.03%2,893

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Omega Fund Management, LLC hold as of Q2 2026?

Omega Fund Management, LLC reported 10 positions worth $185.7M in its Q2 2026 13F filing. Largest positions: BCAX (29.1%), NUVB (24.7%), KMTS (14.0%), BBOT (13.5%) and BBNX (11.1%).

What did Omega Fund Management, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Omega Fund Management, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.